These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2282457)

  • 1. L-arginine and arginine analogues: effects on isolated blood vessels and cultured endothelial cells.
    Schmidt HH; Baeblich SE; Zernikow BC; Klein MM; Böhme E
    Br J Pharmacol; 1990 Sep; 101(1):145-51. PubMed ID: 2282457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of NG-substituted analogues of L-arginine on NANC relaxation of the rat anococcygeus and bovine retractor penis muscles and the bovine penile artery.
    Liu XR; Gillespie JS; Gibson IF; Martin W
    Br J Pharmacol; 1991 Sep; 104(1):53-8. PubMed ID: 1786518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine.
    Hecker M; Mitchell JA; Harris HJ; Katsura M; Thiemermann C; Vane JR
    Biochem Biophys Res Commun; 1990 Mar; 167(3):1037-43. PubMed ID: 2322257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.
    Rees DD; Palmer RM; Schulz R; Hodson HF; Moncada S
    Br J Pharmacol; 1990 Nov; 101(3):746-52. PubMed ID: 1706208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: L-glutamine inhibits the generation of L-arginine by cultured endothelial cells.
    Sessa WC; Hecker M; Mitchell JA; Vane JR
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8607-11. PubMed ID: 1978327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.
    Thiemermann C; Mustafa M; Mester PA; Mitchell JA; Hecker M; Vane JR
    Br J Pharmacol; 1991 Sep; 104(1):31-8. PubMed ID: 1786515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory role of endothelium-derived relaxing factor in rat and human pulmonary arteries.
    Crawley DE; Liu SF; Evans TW; Barnes PJ
    Br J Pharmacol; 1990 Sep; 101(1):166-70. PubMed ID: 2282458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation.
    Rees DD; Palmer RM; Hodson HF; Moncada S
    Br J Pharmacol; 1989 Feb; 96(2):418-24. PubMed ID: 2924084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.
    Moore PK; al-Swayeh OA; Chong NW; Evans RA; Gibson A
    Br J Pharmacol; 1990 Feb; 99(2):408-12. PubMed ID: 2328404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective production of endothelium-derived nitric oxide in canine femoral veins.
    Miller VM
    Am J Physiol; 1991 Sep; 261(3 Pt 2):H677-82. PubMed ID: 1679603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-arginine, but not N alpha-benzoyl-L-arginine ethyl ester, is a precursor of endothelium-derived relaxing factor.
    Fasehun OA; Gross SS; Rubin LE; Jaffe EA; Griffith OW; Levi R
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1348-53. PubMed ID: 2175803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NG-monomethyl-L-arginine and NG-nitro-L-arginine inhibit endothelium-dependent relaxations in human isolated omental arteries.
    Vila J; Esplugues JV; Martinez-Cuesta MA; Martinez-Martinez MC; Aldasoro M; Flor B; Lluch S
    J Pharm Pharmacol; 1991 Dec; 43(12):869-70. PubMed ID: 1687588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors.
    Komas N; Lugnier C; Stoclet JC
    Br J Pharmacol; 1991 Oct; 104(2):495-503. PubMed ID: 1665741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of guanidino compounds on the endothelium-derived relaxing factor inhibitor NG-monomethyl L-arginine.
    Thomas G; Ramwell PW
    J Pharmacol Exp Ther; 1991 Nov; 259(2):490-4. PubMed ID: 1719191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NG-monomethyl-L-arginine paradoxically relaxes preconstricted canine intrapulmonary arteries.
    Tseng CM; Goodman LW; Rubin LJ; Tod ML
    J Appl Physiol (1985); 1993 Feb; 74(2):549-58. PubMed ID: 8458770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasomotor responses of canine coronary arterial rings to NG-monomethyl-L-arginine and N omega nitro L-arginine methyl ester.
    Winn MJ; Asante NK; Ku DD
    J Pharmacol Exp Ther; 1993 Jan; 264(1):265-70. PubMed ID: 8423529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of non-arginine compounds with the endothelium-derived relaxing factor inhibitor, NG-monomethyl L-arginine.
    Thomas G; Ramwell PW
    J Pharmacol Exp Ther; 1992 Feb; 260(2):676-9. PubMed ID: 1310739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction by NG-nitro-L-arginine of H2O2-induced endothelial cell injury.
    Shimizu S; Nomoto M; Yamamoto T; Momose K
    Br J Pharmacol; 1994 Oct; 113(2):564-8. PubMed ID: 7530574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of striatal arginine and citrulline metabolism by nitric oxide synthase inhibitors.
    Ohta K; Shimazu K; Komatsumoto S; Araki N; Shibata M; Fukuuchi Y
    Neuroreport; 1994 Mar; 5(7):766-8. PubMed ID: 7517194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NG-nitro-L-arginine (N5-[imino(nitroamino)methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine.
    Mülsch A; Busse R
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):143-7. PubMed ID: 2314480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.